Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anterix (ATEX) Total Debt (2016 - 2025)

Historic Total Debt for Anterix (ATEX) over the last 12 years, with Q4 2025 value amounting to $9.2 million.

  • Anterix's Total Debt rose 6953.86% to $9.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $9.2 million, marking a year-over-year increase of 6953.86%. This contributed to the annual value of $8.1 million for FY2025, which is 70930.0% up from last year.
  • According to the latest figures from Q4 2025, Anterix's Total Debt is $9.2 million, which was up 6953.86% from $8.8 million recorded in Q3 2025.
  • Anterix's Total Debt's 5-year high stood at $20.2 million during Q3 2022, with a 5-year trough of $120000.0 in Q1 2022.
  • Moreover, its 5-year median value for Total Debt was $1.2 million (2023), whereas its average is $6.9 million.
  • Data for Anterix's Total Debt shows a peak YoY increase of 1677416.67% (in 2023) and a maximum YoY decrease of 9506.15% (in 2023) over the last 5 years.
  • Over the past 5 years, Anterix's Total Debt (Quarter) stood at $280000.0 in 2021, then skyrocketed by 7131.79% to $20.2 million in 2022, then plummeted by 95.06% to $1.0 million in 2023, then skyrocketed by 439.7% to $5.4 million in 2024, then skyrocketed by 69.54% to $9.2 million in 2025.
  • Its Total Debt stands at $9.2 million for Q4 2025, versus $8.8 million for Q3 2025 and $19.1 million for Q2 2025.